• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Precision Psychiatry: Circular Genomics Secures $8.3M to Tackle Depression with CircRNA Test

by Fred Pennic 01/26/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Precision Psychiatry: Circular Genomics Secures $8.3M to Tackle Depression with CircRNA Test

What You Should Know:

– Circular Genomics, a pioneer in unlocking the secrets of circular RNA (circRNA) for precision psychiatry and neurology, has secured $8.3 million in a Series A funding round. Led by Mountain Group Partners, this vital investment brings on board new partner UNM Rainforest Innovations and bolsters support from existing investors like Cottonwood Technology Fund and Tramway Venture Partners.

– The new funding will empower Circular Genomics to build and scale commercial operations, improve patient care and boost patient hope. This groundbreaking test promises to transform the way we approach depression, offering a glimpse into a patient’s individual response to antidepressant medications before they even begin treatment.

A Beacon of Hope for Millions Battling Depression

Millions grapple with depression, often facing a frustrating and lengthy journey to find the right medication. Current treatments often involve trial-and-error, leading to disappointment and potentially harmful side effects. Circular Genomics’ innovative test aims to break this cycle by providing clinicians with a powerful tool to predict a patient’s likelihood of success with specific antidepressants.

Unveiling the Power of CircRNA

Precision Psychiatry: Circular Genomics Secures $8.3M to Tackle Depression with CircRNA Test

CircRNA is a unique type of RNA molecule with a closed loop structure, offering potential insights into the complex mechanisms of neurological disorders like depression. Circular Genomics’ groundbreaking research has identified specific circRNAs linked to treatment response, unlocking a new avenue for personalized medicine in mental health.

Transforming the Landscape of Depression Care

This transformative test holds immense potential benefits:

  • Improved patient outcomes: Early identification of responders and non-responders allows for more targeted treatment plans, leading to faster symptom relief and improved quality of life.
  • Reduced healthcare costs: By avoiding ineffective treatments and associated side effects, the test can optimize resource allocation and lower healthcare costs.
  • Deeper understanding of depression: By analyzing circRNA expression patterns, researchers can gain valuable insights into the biological underpinnings of depression, paving the way for more effective treatment development.

Circular Genomics stands at the forefront of a paradigm shift in mental healthcare. Their innovative approach, fueled by this significant investment, promises a future where depression treatment is tailored to the individual, offering hope and a brighter future for millions struggling with this debilitating condition.

Swati Mathai, co-founder and CEO of XO Health, states: “Our vision is to create a healthcare system where trust, transparency, and optimal outcomes go hand-in-hand. Innovaccer’s platform serves as our foundational partner, removing artificial barriers and allowing us to build a unified member experience. Together, we’re pioneering a unique solution with a single source of truth for member data, leading to more effective interactions between individuals and their providers.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |